טוען...

An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs

Adeno-associated virus (AAV) vectors have been successfully applied in hemophilia clinical trials. However, this approach is limited to patients without AAV-neutralizing antibodies (NAbs). In this study, we explored the feasibility of AAV re-administration in hemophilia A dogs treated initially 8 ye...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Mol Ther Methods Clin Dev
Main Authors: Sun, Junjiang, Shao, Wenwei, Chen, Xiaojing, Merricks, Elizabeth P., Wimsey, Lauren, Abajas, Yasmina L., Niemeyer, Glenn P., Lothrop, Clinton D., Monahan, Paul E., Samulski, R. Jude, Nichols, Timothy C., Li, Chengwen
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society of Gene & Cell Therapy 2018
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6104583/
https://ncbi.nlm.nih.gov/pubmed/30140713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2018.07.011
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!